Two studies were published in the impactful New England Journal of Medicine [Reference Weghuber, Barrett and Barrientos-Prez1,Reference Arslanian, Hannon and Zeitler2], research motivated, as noted by the authors, in no small measure precisely because the currently approved medications for pediatric obesity and type 2 diabetes have proven to be limited in their effectiveness and fraught with adverse events [Reference Woodard, Louque and Hsia3]
For laboratory applications, it may be reconstituted with bacteriostatic water or another suitable solvent, following standard peptide-handling protocols
Results: A total of 23 RCTs with 1,917 patients and 10 kids of antioxidants were included
Furthermore, factors such as study population characteristics, duration of supplementation, and the specific growth parameters measured (short-term weight gain velocity vs